Molecular Diagnostics Market to grow at 8.1
Get more details @ http://bit.ly/2oUDIou Key industry players include Abbott Laboratories, Alere, Becton Dickinson, Bayer Healthcare, Bio-Rad Laboratories, Dako, bioMerieux, Cepheid, Hologic (Gen Probe), Danaher Corporation, Novartis (Grifols), Siemens Healthcare, Roche Diagnostics, Johnson & Johnson, Qiagen, and Sysmex Corporation.
Get more details @ http://bit.ly/2oUDIou
Key industry players include Abbott Laboratories, Alere, Becton Dickinson, Bayer Healthcare, Bio-Rad Laboratories, Dako, bioMerieux, Cepheid, Hologic (Gen Probe), Danaher Corporation, Novartis (Grifols), Siemens Healthcare, Roche Diagnostics, Johnson & Johnson, Qiagen, and Sysmex Corporation.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> forecast <strong>to</strong> hit $10bn<br />
by 2023: Global <strong>Market</strong> Insights Inc.<br />
The medical report “<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> Size By Infectious Disease (Flu,<br />
Tuberculosis, Meningitis, RSV Virus, Hep<strong>at</strong>itis B, Hep<strong>at</strong>itis C, HPV, STD, HIV,<br />
Dengue, Gonorrhea, Chlamydia, TORCH, H. Pylori), By Technology (PCR, Real-<br />
Time PCR, DNA/RNA Purific<strong>at</strong>ion), Industry Analysis Report, Regional Outlook<br />
(U.S., Canada, Germany, UK, France, Spain, Portugal, Italy, Russia, Denmark,<br />
Norway, Sweden, Israel, Japan, China, India, Sri Lanka, Pakistan, Philippines,<br />
South Korea, Australia, New Zealand, Vietnam, Thailand, Mexico, Brazil,<br />
Argentina, Colombia, Chile, Peru, South Africa, Nigeria, Morocco, Egypt, KSA,<br />
UAE, Jordan, Q<strong>at</strong>ar), Applic<strong>at</strong>ion Potential, Price Trend, Competitive <strong>Market</strong><br />
Share & Forecast, 2016 - 2023”, by Global <strong>Market</strong> Insights, Inc., The <strong>Molecular</strong><br />
<strong>Diagnostics</strong> <strong>Market</strong> size is anticip<strong>at</strong>ed <strong>to</strong> exceed USD 10 billion by 2023.<br />
Rampant use of advanced PoC (point of care) diagnostics devices across the<br />
healthcare sec<strong>to</strong>r will spur molecular diagnostics market <strong>grow</strong>th. A swift rise in the<br />
aging popul<strong>at</strong>ion prone <strong>to</strong> chronic ailments is expected <strong>to</strong> offer huge potential for the<br />
industry <strong>grow</strong>th. As per UN reports, the older popul<strong>at</strong>ion (> 65 years) is expected <strong>to</strong><br />
rise from 901 million in 2015 <strong>to</strong> nearly 2.1 billion by 2050. Furthermore, heavy<br />
demand for personalized drugs as well as companion diagnostics along with high<br />
expenditure on activities pertaining <strong>to</strong> medical diagnostics clinical research will drive<br />
the market trends over the coming six years.<br />
DNA/RNA Purific<strong>at</strong>ion, PCR (Polymerase chain reaction), and Real-Time PCR are<br />
some of the key molecular diagnostics technologies. PCR, which accounted for 46%<br />
of molecular diagnostics industry share in 2015, is expected <strong>to</strong> contribute<br />
significantly <strong>to</strong>wards the overall revenue over the coming timeframe. Real time PCR<br />
is also expected <strong>to</strong> make substantial contributions <strong>to</strong>wards molecular diagnostics<br />
market size, driven by breakthroughs in clinical microbiology, molecular biology, and<br />
instrument<strong>at</strong>ion.<br />
Contagious diseases such as tuberculosis, hep<strong>at</strong>itis C, flu, RSV (Respira<strong>to</strong>ry<br />
syncytial virus), meningitis, hep<strong>at</strong>itis B, HPV (human papillomavirus), Dengue, and<br />
STD (Sexually Transmitted Disease) are projected <strong>to</strong> contribute significantly <strong>to</strong>wards<br />
molecular diagnostics market revenue over the next few years. STD, which covered<br />
a major portion of the overall revenue in 2015, is expected <strong>to</strong> offer lucr<strong>at</strong>ive <strong>grow</strong>th<br />
opportunities for the industry over the next few years. High occurrence of sexually<br />
transmitted diseases along with the use of advanced diagnostic procedures will drive<br />
1 | P a g e
the <strong>grow</strong>th. HPV is anticip<strong>at</strong>ed <strong>to</strong> nurture molecular diagnostics industry <strong>grow</strong>th over<br />
2016-2023. Rise in HPV infections across the globe is expected <strong>to</strong> drive the <strong>grow</strong>th.<br />
Germany <strong>Molecular</strong> diagnostics market size, by technology, 2012-2023 (USD<br />
Million)<br />
Browse key industry insights spread across 115 pages with 142 market d<strong>at</strong>a tables &<br />
9 figures & charts from the report, “<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>” in detail along<br />
with the table of contents:<br />
https://www.gminsights.com/industry-analysis/molecular-diagnostics-market-report<br />
Below are the regional trends influencing molecular diagnostics market over<br />
2016-2023:<br />
APAC molecular diagnostics industry size is expected <strong>to</strong> <strong>grow</strong> considerably over the<br />
coming timeframe. Rise in incidence of contagious diseases as well HAIs (hospital<br />
acquired infections), high p<strong>at</strong>ient popul<strong>at</strong>ion base, fast economic development, and<br />
preventive healthcare legisl<strong>at</strong>ions will be the key driving fac<strong>to</strong>rs. China, Malaysia,<br />
and India are predicted <strong>to</strong> be the major regional revenue contribu<strong>to</strong>rs.<br />
Introduction of new technologies, enhanced healthcare facilities, increase in p<strong>at</strong>ient<br />
awareness level regarding early diagnosis of the ailment, and heavy funding for R&D<br />
activities associ<strong>at</strong>ed with drug discovery will boost North America molecular<br />
diagnostics market revenue over the coming six years. U.S. is expected <strong>to</strong> be the<br />
key regional <strong>grow</strong>th driver.<br />
Large acceptance of modern technologies along with high investments across the<br />
healthcare sec<strong>to</strong>r <strong>to</strong> improve the care services is expected <strong>to</strong> acceler<strong>at</strong>e Europe<br />
molecular diagnostics industry <strong>grow</strong>th. Germany is projected <strong>to</strong> contribute<br />
considerably <strong>to</strong>wards the regional share.<br />
2 | P a g e
Africa molecular diagnostics industry revenue, estim<strong>at</strong>ed <strong>at</strong> over USD 130 million in<br />
2015, is expected <strong>to</strong> <strong>grow</strong> <strong>at</strong> a r<strong>at</strong>e of 9.5% over 2016-2023. High acceptance of<br />
novel technologies such as PoC diagnostic kits plus rise in occurrence of contagious<br />
diseases is forecast <strong>to</strong> drive the regional <strong>grow</strong>th.<br />
<strong>Market</strong> players will try <strong>to</strong> expand their product portfolio through str<strong>at</strong>egic<br />
collabor<strong>at</strong>ions and joint ventures. Key industry participants include Johnson &<br />
Johnson, bioMerieux, Bec<strong>to</strong>n Dickinson, Abbott Labora<strong>to</strong>ries, Danaher Corpor<strong>at</strong>ion,<br />
Cepheid, Bio-Rad Labora<strong>to</strong>ries, Bayer Healthcare, F. Hoffmann-La Roche AG,<br />
Siemens Healthcare, Dako, and Novartis.<br />
Table of Content of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>:<br />
Chapter 1.<br />
Methodology and Scope<br />
1.1. Research Methodology<br />
1.1.1. Initial d<strong>at</strong>a explor<strong>at</strong>ion<br />
1.1.2. St<strong>at</strong>istical model and forecast<br />
1.1.3. Industry insights and valid<strong>at</strong>ion<br />
1.1.4. Research scope and assumptions<br />
1.2. D<strong>at</strong>a Sources<br />
1.2.1. Primary sources<br />
1.2.2. Secondary sources<br />
Chapter 2.<br />
Executive Summary<br />
2.1. <strong>Molecular</strong> <strong>Diagnostics</strong> industry 3600 synopsis, 2012 - 2023<br />
2.1.1. Business trends<br />
2.1.2. Disease trends<br />
2.1.3. Technological trends<br />
2.1.4. Regional trends<br />
Chapter 3.<br />
<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> Industry Insights<br />
3 | P a g e
3.1. Industry segment<strong>at</strong>ion<br />
3.2. Industry size and forecast, 2012 - 2023<br />
3.3. Industry impact forces<br />
3.3.1. Growth drivers<br />
3.3.1.1. Technological advancements<br />
3.3.1.2. Growing POC demand<br />
3.3.1.3. Increasing geri<strong>at</strong>ric popul<strong>at</strong>ion<br />
3.3.1.4. Considerable R&D initi<strong>at</strong>ives<br />
3.3.2. Industry pitfalls & challenges<br />
3.3.2.1. Unclear regula<strong>to</strong>ry landscape<br />
3.3.2.2. Cost concerns<br />
3.4. Growth potential analysis<br />
3.5. Regional opportunities<br />
3.6. Disease type opportunities<br />
3.7. Porter’s analysis<br />
3.8. PESTEL analysis<br />
3.9. Company market share analysis, 2015<br />
3.9.1. Key product landscape<br />
3.9.2. Competitive landscape<br />
About Global <strong>Market</strong> Insights:<br />
Global <strong>Market</strong> Insights, Inc., headquartered in Delaware, U.S., is a global market research<br />
and consulting service provider; offering syndic<strong>at</strong>ed and cus<strong>to</strong>m research reports along with<br />
<strong>grow</strong>th consulting services. Our business intelligence and industry research reports offer<br />
clients with penetr<strong>at</strong>ive insights and actionable market d<strong>at</strong>a specially designed and<br />
presented <strong>to</strong> aid str<strong>at</strong>egic decision making. These exhaustive reports are designed via a<br />
4 | P a g e
proprietary research methodology and are available for key industries such as chemicals,<br />
advanced m<strong>at</strong>erials, technology, renewable energy and biotechnology.<br />
Contact Us:<br />
Arun Hegde<br />
Corpor<strong>at</strong>e Sales, USA<br />
Global <strong>Market</strong> Insights, Inc.<br />
Phone: 1-302-846-7766<br />
Toll Free: 1-888-689-0688<br />
Email: sales@gminsights.com<br />
Website: https://www.gminsights.com/<br />
5 | P a g e
Change language